Publicacións nas que colabora con Oreste Gualillo (10)

2023

  1. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

    Biomedicine and Pharmacotherapy, Vol. 161

2022

  1. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

2021

  1. Evaluation of Virola oleifera activity in musculoskeletal pathologies: Inhibition of human multiple myeloma cells proliferation and combination therapy with dexamethasone or bortezomib

    Journal of Ethnopharmacology, Vol. 272

  2. Pharmacological Extracts and Molecules from Virola Species: Traditional Uses, Phytochemistry, and Biological Activity

    Molecules (Basel, Switzerland), Vol. 26, Núm. 4

2019

  1. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

2013

  1. Ghrelin requires p53 to stimulate lipid storage in fat and liver

    Endocrinology, Vol. 154, Núm. 10, pp. 3671-3679

2003

  1. Hypothalamic levels of NPY, MCH, and prepro-orexin mRNA during pregnancy and lactation in the rat: Role of prolactin

    FASEB Journal, Vol. 17, Núm. 11, pp. 1392-1400

2001

  1. Effect of cyclic 3′,5′-adenosine monophosphate, glucocorticoids, and insulin on leptin messenger RNA levels and leptin secretion in cultured human trophoblast

    Biology of Reproduction, Vol. 65, Núm. 3, pp. 814-819

  2. Hormonal control of growth hormone secretion

    Hormone Research

1999

  1. Prolactin stimulates leptin secretion by rat white adipose tissue

    Endocrinology, Vol. 140, Núm. 11, pp. 5149-5153